Clinical trials: KSHV Inflammatory Cytokine Syndrome (KICS), open to volunteers
KSHV Inflammatory Cytokine Syndrome (KICS), KSHV
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
Background: KSHV inflammatory cytokine syndrome (KICS) is a newly recognized disease caused by Kaposi sarcoma-associated herpesvirus (KSHV). This virus can cause cancer. People with KICS can have severe symptoms.
- Conditions
- KSHV Inflammatory Cytokine Syndrome (KICS), KSHV, HHV-8
- Trial name
- NCT01419561
- Testing
- Zidovudine, Liposomal Doxorubicin, Valganiclovir
- Where
- United States
- Volunteers
- 140 people
- Sponsor
- National Cancer Institute (NCI)
KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
Background: Kaposi sarcoma herpesvirus (KSHV)-associated inflammatory cytokine syndrome (KICS) and KSHV-multicentric Castleman disease (MCD) occur in people living with HIV.
- Trial name
- NCT06052618
- Testing
- Pacritinib
- Where
- United States
- Volunteers
- 75 people
- Sponsor
- National Cancer Institute (NCI)